MedPath

BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

90411

Prescription Type

Uso Hospitalario

Authorization Date

Jun 26, 2025

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number90411
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

BOSUTINIB DIHIDRATOActive
Quantity: 427,16 mg
Name: BOSUTINIB DIHIDRATO

ATC CLASSIFICATION (3)

L01E
L01EA
L01EA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.